PXR ablation alleviates steatohepatitis in high-fat diet-induced obesity mice and genetic obesity model ob/ob mice, suggesting the therapeutic potential of PXR antagonists in NAFLD [223]. This evidence concerns the gene NR1I2 and Obesity.